» Articles » PMID: 19401490

The Airway Vasculature: Recent Advances and Clinical Implications

Overview
Journal Thorax
Date 2009 Apr 30
PMID 19401490
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

It is increasingly recognised that the airway circulation plays an important role in airway diseases, either through a change in blood flow or through microvascular leakage. Most of the information available regarding the anatomy and physiology of bronchial blood flow and its regulation has necessarily derived from animal studies. However, there have recently been important advances in understanding airway blood flow in airway disease in humans through the development of non-invasive methods and in the quantification of microvascular leakage using plasma markers. These studies have shown that bronchial blood flow is increased in patients with asthma but not in those with chronic obstructive pulmonary disease, confirming previous pathology investigations. Changes in bronchial blood flow may in part reflect the generation of new vascular vessels, a process known as "angiogenesis" which is caused by airway inflammation. Angiogenesis and the resulting plasma leak affect airway physiology, drug clearance and its bioavailability. This review discusses the anatomy, physiology and regulation of bronchial blood flow in the normal and diseased lung, In addition, it analyses the effect of current medical treatment and discusses the potential use of new anti-angiogenesis medications. The development of non-invasive assessment of bronchial blood flow and the study of angiogenesis have provided a tool to investigate airway physiology in vivo; these advances will contribute to a better understanding of inflammatory airway diseases as well as the implication of these findings to management.

Citing Articles

The role of vasculature and angiogenesis in respiratory diseases.

Ackermann M, Werlein C, Plucinski E, Leypold S, Kuhnel M, Verleden S Angiogenesis. 2024; 27(3):293-310.

PMID: 38580869 PMC: 11303512. DOI: 10.1007/s10456-024-09910-2.


High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET.

Wang Y, Abdelhafez Y, Spencer B, Verma R, Parikh M, Stollenwerk N J Nucl Med. 2024; 65(5):714-721.

PMID: 38548347 PMC: 11064825. DOI: 10.2967/jnumed.123.267036.


An Update on Advancements and Challenges in Inhalational Drug Delivery for Pulmonary Arterial Hypertension.

Agnihotri V, Agrawal Y, Goyal S, Sharma C, Ojha S Molecules. 2022; 27(11).

PMID: 35684428 PMC: 9182169. DOI: 10.3390/molecules27113490.


The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.

Dhand R J Aerosol Med Pulm Drug Deliv. 2017; 31(3):121-138.

PMID: 29077527 PMC: 5994662. DOI: 10.1089/jamp.2017.1415.


Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series).

Kropski J, Richmond B, Gaskill C, Foronjy R, Majka S Pulm Circ. 2017; 8(1):2045893217739807.

PMID: 29040010 PMC: 5731726. DOI: 10.1177/2045893217739807.